Volume 15 Issue 1 - International Pharmaceutical Industry

Current Edition

Volume 15 Issue 1

In-flight Data Control

How to Approach the Next Frontier in Transforming Life Sciences Business Process Efficiency. The trouble with non-standardised data, from an internal company pers...

3 July 2023 Volume 15 Issue 1 company | control

Continue Reading →

Volume 15 Issue 1

Intellectual Property Matters for Economic, Social, Technological, Scientific, and Industrial Development

Q: SPL – Please tell us about ARIPO. Why was ARIPO formed and what are your core functions and visions of ARIPO? A: The African Regional Intellectual Property Org...

4 April 2023 Volume 15 Issue 1 ARIPO | healthcare

Continue Reading →

Volume 15 Issue 1

IPI speaks with experts at PharmaLex on Integrated Product Development

Q: Can we start with a brief history of PharmaLex, what are your key offerings into the industry? A: PharmaLex was established 25 years ago with a vision to make ...

4 April 2023 Volume 15 Issue 1 development | interview

Continue Reading →

Volume 15 Issue 1

How Are Emerging Biotechs Harnessing Strategic Partnerships to Strengthen Their Journey to Commercialisation?

Forecasted to reach $108 billion by 2023, the global pharmaceutical services outsourcing market is currently undergoing incredible levels of growth. Organisations...

4 April 2023 Volume 15 Issue 1 Biotechs | Commercialisation

Continue Reading →

Volume 15 Issue 1

Navigating the Data-driven Future of Life Sciences Regulatory Processes: Who Will Take the Lead?

Generis hosted a live video discussion with a panel of industry thought leaders from BioNTech, Bayer, Iperion – a Deloitte business, and Beczek. COM to discuss the c...

4 April 2023 Volume 15 Issue 1 data | healthcare

Continue Reading →

Volume 15 Issue 1

Data Transformation to Accelerate Time to Market and Address Product Shortages in Life Sciences Postpandemic

Frits Stulp of Iperion, a Deloitte business, predicts that a wave of data-driven transformation that began in 2022 will enhance insights and decision-making, allowin...

4 April 2023 Volume 15 Issue 1 healthcare | pandemic

Continue Reading →

Volume 15 Issue 1

Navigating the Changing Oral Solid Dose Landscape

Oral solid dose (OSD) forms have accounted for the lion’s share of the pharmaceutical market for decades, thanks to their easy administration leading to patient conv...

4 April 2023 Volume 15 Issue 1 development | dosage

Continue Reading →

Volume 15 Issue 1

Fulfilling the Potential of Drug R&D: Six Predictions for 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that e...

4 April 2023 Volume 15 Issue 1 clinical | development

Continue Reading →

Volume 15 Issue 1

Into the Future with Next-generation Small Molecules

Heightened interest in small molecules is likely to continue in 2023 and beyond as several biotech companies look beyond biologics to bring medicines to patients in ...

4 April 2023 Volume 15 Issue 1 biotechnology | Innovations

Continue Reading →

Volume 15 Issue 1

How Decentralised and Hybrid Clinical Trials Can Support Subject Recruitment and Retention to Support Clinical Trial Success

Decentralised and hybrid clinical trials are delivering benefits for sponsors in a number of ways – delivering quality data quicker to reduce time to market, achievi...

4 April 2023 Volume 15 Issue 1 clinical trials | COVID-19

Continue Reading →